Proteomics International presented at the 121 Tech Investment Summit in Hong Kong. The 121 Summit is a dedicated forum connecting growth stage tech companies to investors across the Sino-sphere.

Investor Presentation

The event follows our highly successful participation in the American Diabetes Association 79th Scientific Sessions in San Francisco, and the world’s premier biotechnology conference – BIO 2019  in Philadelphia.

The three events highlight our on-going engagement with global diagnostics and pharma companies for the roll-out of PromarkerD.